Oral medications for treating diabetes mellitus in dogs and cats

Journal of Small Animal Practice

Volumn 41, Issue 11, 2000, Pages 486-490

  Nelson, R W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; VETERINARY DRUG;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DIABETES MELLITUS; DOG; DOG DISEASE; ORAL DRUG ADMINISTRATION; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; CAT DISEASES; CATS; DIABETES MELLITUS; DOG DISEASES; DOGS; HYPOGLYCEMIC AGENTS; VETERINARY DRUGS;

EID: 0034331698     PISSN: 00224510     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-5827.2000.tb03969.x     Document Type: Article

References (45)

1. ABRAHAM, A. S., BROOKS, B. A. & EYLATH, U. (1992) The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41, 768-771
2. ANDERSON, R. A. (1992) Chromium, glucose tolerance, and diabetes. Biological Trace Element Research 32, 19-24
3. ANDERSON, R. A., CHENG, N., BRYDEN, N. A., POLANSKY, M. M., CHENG, N., CHI, J. & FENG, J. (1997) Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46, 1785-1791
4. BAILEY, C. J. & TURNER, R. C. (1996) Metformin. New England Journal of Medicine 334, 574-579
5. BALFOUR, J. A. & MCTAVISH, D. (1993) Acarbose: an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 46, 1025-1054
6. BERGER, J., BAILEY, P., BISWAS, C., CULLINAN, C., DOEBBER, T., HAYES, N., SAPERSTEIN, R., SMITH, R. & LEIBOWITZ, M. (1996) Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ binding and activation correlated with antidiabetic actions in db/db mice. Endocrinology 137, 4189-4195
7. BRICHARD, S. M. & HENQUIN, J. (1995) The role of vanadium in the management of diabetes. Trends in Pharmacological Sciences 16, 265-270
8. COHEN, N., HALBERSTAM, M., SHLIMOVICH, P., CHANG, C., SHAMOON, H. & ROSSETTI, L. (1995) Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 95, 2501-2509
9. COHN, L. A., DODAM, J. R., MCCAW, D. L. & TATE, D. J. (1999) Effects of chromium supplementation on glucose tolerance in obese and nonobese cats. American Journal of Veterinary Research 60, 1360-1363
10. CONIFF, R. F., SHAPIRO, J. A., ROBBINS, D., KLEINFIELD, R., SEATON, T., BEISSWENGER, P. & MCGILL, J. (1995) Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study. Diabetes Care 18, 817-824
11. DAMSBO, P., CLAUSON, P., MARBURY, T. C. & WINDFELD, K. (1999) A double-blind randomized comparison of meal-related glycaemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients. Diabetes Care 22, 789-794
12. DEFRONZO, R. A. (1999) Pharmacologic therapy for type 2 diabetes mellitus. Annals of Internal Medicine 131, 281-303
13. DEFRONZO, R. A. & GOODMAN, A. M. (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. New England Journal of Medicine 333, 541-549
14. EVANS, G. W. (1989) The effect of chromium picolinate on insulin controlled parameters in humans. International Journal of Biosocial and Medical Research 11, 163-180
15. FELDMAN, E. C. & NELSON, R. W. (1996) Diabetes mellitus. In: Canine and Feline Endocrinology and Reproduction, 2nd edn. Eds E. C. Feldman and R. W. Nelson. W. B. Saunders, Philadelphia. pp 339-391
16. FELDMAN, E. C., NELSON, R. W. & FELDMAN, M. S. (1997) Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. Journal of the American Veterinary Medical Association 210, 772-777
17. FONDACARO, J. V., GRECO, D. S. & CRANS, D. C. (1999) Treatment of feline diabetes mellitus with protamine zinc analine insulin (PZI) alone compared with PZI and oral vanadium dipicolinate. Journal of Veterinary Internal Medicine 13, 244 (abstract)
18. GITLIN, N., JULIE, N. L., SPURR, C. L., LIM, K. N. & JUARBE, H. M. (1998) Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone. Annals of Internal Medicine 129, 36-38
19. GOLDFINE, A. B., SIMONSON, D. C., FOLLI, F., PATTI, M. & KAHN, R. (1995) In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Molecular and Cellular Biochemistry 153, 217-231
20. GRECO, D. S. (2000) Treatment of non-insulin-dependent diabetes mellitus in cats using oral hypoglycemic agents. In: Kirk's Current Veterinary Therapy XIII. Ed J. D. Bonagura. W. B. Saunders, Philadelphia. pp 350-354
21. GROSS, K. L., WEDEKIND, K. J., KIRK, C. A., SCHOENHERR, W. D., LOWRY, S. R. & OWEN, K. Q. (2000) Dietary chromium and carnitine supplementation does not affect glucose tolerance in obese dogs. Journal of Veterinary Internal Medicine 14, 345 (abstract)
22. GROSSMAN, S. & LESSEM, J. (1997) Mechanisms and clinical effects of thiazolidinediones. Expert Opinion on Investigational Drugs 6, 1025-1040
23. HILLEBRAND, I., BOEHME, K., FRANK, G., FINK, H. & BERCHTOLD, P. (1979) The effects of the α-glucosidase inhibitor BAY g 5421 (acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man. Research in Experimental Medicine 175, 81-86
24. KELLEY, D. E., BIDOT, P., FREEDMAN, Z., HAAG, B., PODLECKI, D., RENDELL, M., SCHIMEL, D., WEISS, S., TAYLOR, T., KROL, A. & MAGNER, J. (1998) Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes. Diabetes Care 21, 2056-2061
25. LEMBCKE, B., FOLSCH, U. R. & CREUTZFELDT, W. (1985) Effect of 1-desoxynojirimycin derivatives on small intestinal disaccharidase activities and on active transport in vitro. Digestion 31, 120-127
26. MICHELS, G. M., BOUDINOT, F. D., FERGUSON, D. C. & HOENIG, M. (1999) Pharmacokinetics of the anti-hyperglycemic agent metformin in cats. American Journal of Veterinary Research 60, 738-742
27. MICHELS, G. M., BOUDINOT, F. D., FERGUSON, D. C. & HOENIG, M. (2000) Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats. American Journal of Veterinary Research 61, 775-778
28. MILLER, A. B., NELSON, R. W., KIRK, C. A. & FELDMAN, E. C. (1992) Effect of glipizide on serum insulin and glucose concentrations in healthy cats. Research in Veterinary Science 52, 177-181
29. MOSES, R., SLOBODNIUK, R., BOYAGES, S., COLAGIURI, S., KIDSON, W. & CARTER, J. (1999) Effect of repaglinide addition to metformin monotherapy on glycaemic control in patients with type 2 diabetes. Diabetes Care 22, 119-124
30. MOSSOP, R. T. (1983) Effects of chromium (III) on fasting glucose, cholesterol, and cholesterol HDL levels in diabetics. Central African Journal of Medicine 29, 80-82
31. NELSON, R. W., FELDMAN, E. C., FORD, S. L. & ROEMER, O. P. (1993) Effect of an orally administered sulfonyl-urea, glipizide, for treatment of diabetes mellitus in cats. Journal of the American Veterinary Medical Association 203, 821-827
32. NELSON, R. W., GRIFFEY, S. M., FELDMAN, E. C. & FORD, S. L. (1999) Transient clinical diabetes mellitus in cats: 10 cases (1989-1991). Journal of Veterinary Internal Medicine 13, 28-35
33. NELSON, R. W., ROBERTSON, J., FELDMAN, E. C. & BRIGGS, C. (2000) Effect of the α-glucosidase inhibitor acarbose on control of glycaemia in dogs with naturally acquired diabetes mellitus. Journal of the American Veterinary Medical Association 216, 1265-1269
34. PATEL, J., MILLER, E., HU, J. & GRANETT, J. (1997) BRL 49653 (a thiazolidinedione) improves glycaemic control in NIDDM patients. Diabetes 46 (Supplement 1), 150A (abstract)
35. PLOSKER, G. L. & FAULDS, D. (1999) Troglitazone. A review of its use in the management of type 2 diabetes mellitus. Drugs 57, 409-438
36. RABINOWITZ, M. B., GONICK, H. C., LEVIN, S. R. & DAVIDSON, M. D. (1983) Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6, 319-327
37. RIOS, M. S. (1994) Acarbose and insulin therapy in type I diabetes mellitus. European Journal of Clinical Investigation 24, 36-39
38. ROBERTSON, J., NELSON, R. W., KASS, P. & NEAL, L. (1999) Effects of the α-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs. American Journal of Veterinary Research 60, 541-545
39. SAMBOL, N. C., CHIANG, J., O'CONNER, M., LIU, C. Y., LIN, E. T., GOODMAN, A. M., BENET, L. Z. & KARAM, J. H. (1996) Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Pharmacology 36, 1012-1021
40. SCHACHTER, S., NELSON, R. W. & KIRK, C. A. (2000) Effect of oral chromium picolinate on glycaemic control in insulin-treated diabetic dogs. Journal of Veterinary Internal Medicine 14, 345 (abstract)
41. SHEEN, A. J. (1996) Clinical pharmacokinetics of metformin. Clinical Pharmacokinetics 30, 359-371
42. SPANN, D., NELSON, R. W., VULLIET, R. & RONDOS, B. (2000) Evaluation of metformin in healthy and diabetic cats. Journal of Veterinary Internal Medicine 14, 345 (abstract)
43. SPEARS, J. W., BROWN, T. T., SUNVOLD, G. D. & HAYEK, M. G. (1998) Influence of chromium on glucose metabolism and insulin sensitivity. In: Recent Advances in Canine and Feline Nutrition, Vol II. Eds G. A. Reinhart and D. P. Carey. Orange Frazer Press, Wilmington, Ohio, pp 97-102
44. STRIFFLER, J. S., LAW, J. S., POLANSKY, M. M., BHATHENA, S. J. & ANDERSON, R. A. (1995) Chromium improves insulin response to glucose in rats. Metabolism 44, 1314-1320
45. WOLFFENBUTTEL, B. H. R. & LANDGRAF, R. (1999) A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care 22, 463-467